Profile data is unavailable for this security.
About the company
cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.
- Revenue in USD (TTM)20.64m
- Net income in USD-23.42m
- Incorporated2015
- Employees52.00
- LocationcbdMD Inc8845 Red Oak BlvdCHARLOTTE 28217-5593United StatesUSA
- Phone+1 (704) 445-3060
- Websitehttps://www.cbdmd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evofem Biosciences Inc | 17.10m | -11.02m | 1.00m | 37.00 | -- | -- | -- | 0.0586 | -0.6139 | -0.6139 | 0.039 | -0.6591 | 0.9177 | 1.64 | 2.92 | 462,108.10 | -42.60 | -211.64 | -- | -- | 80.84 | -- | -46.42 | -1,031.55 | 0.0933 | -- | -- | -- | 8.20 | -- | 164.08 | -- | -10.59 | -- |
| Nexien Biopharma Inc | 0.00 | -196.19k | 1.06m | 0.00 | -- | -- | -- | -- | -0.0029 | -0.0029 | 0.00 | -0.0056 | 0.00 | -- | -- | -- | -1,453.26 | -1,542.27 | -- | -- | -- | -- | -- | -- | -- | -1.26 | -- | -- | -- | -- | 33.93 | -- | -- | -- |
| Bespoke Extracts Inc | 1.08m | -1.12m | 1.20m | 10.00 | -- | -- | -- | 1.12 | -0.1089 | -0.1089 | 0.105 | -0.2094 | 2.97 | 16.99 | 23.47 | 107,984.00 | -308.41 | -- | -- | -- | 45.10 | -- | -103.69 | -- | 0.0462 | -27.50 | -- | -- | 22,933.72 | -- | 63.98 | -- | -- | -- |
| Agentix Corp | 0.00 | -238.02k | 1.45m | -- | -- | -- | -- | -- | -0.0059 | -0.0059 | 0.00 | -0.0708 | 0.00 | -- | -- | -- | -94.52 | -- | -- | -- | -- | -- | -- | -- | -- | -74.08 | -- | -- | -- | -- | 57.41 | -- | -- | -- |
| Mallinckrodt PLC | 1.96bn | 917.30m | 1.60m | 2.80k | -- | -- | 0.0015 | 0.0008 | 20.19 | 20.21 | 79.87 | 52.21 | 0.4641 | 1.68 | 4.83 | 698,892.90 | 21.76 | -12.49 | 25.91 | -15.85 | 33.77 | 35.68 | 46.88 | -44.38 | 1.83 | -0.0138 | 0.6286 | -- | -2.53 | -10.31 | -83.00 | -- | -- | -- |
| 60 Degrees Pharmaceuticals Inc | 462.61k | -8.39m | 1.63m | 3.00 | -- | -- | -- | 3.52 | -9.19 | -9.19 | 0.3867 | 3.24 | 0.0558 | 0.7863 | 2.00 | 154,203.30 | -95.99 | -- | -123.36 | -- | 10.73 | -- | -1,719.15 | -- | 4.91 | -- | 0.0256 | -- | -50.40 | -- | 35.51 | -- | -- | -- |
| Procyon Corp | 4.98m | -312.97k | 1.63m | 19.00 | -- | 0.7512 | -- | 0.3274 | -0.0387 | -0.0387 | 0.6138 | 0.2817 | 1.47 | 2.32 | 9.90 | 262,338.40 | -10.08 | 1.19 | -12.70 | 1.44 | 78.07 | 74.40 | -6.84 | 0.8691 | 2.41 | -- | 0.00 | -- | 6.35 | 3.53 | -367.38 | -- | 17.32 | -- |
| Stemcell Holdings Inc | 9.98m | 3.10m | 1.64m | -- | -- | -- | 0.5008 | 0.1645 | 0.00008 | 0.00008 | 0.0003 | 0.0002 | 1.12 | -- | 5.20 | -- | 34.90 | -- | 68.19 | -- | 77.19 | -- | 31.04 | -- | -- | -- | 0.00 | -- | 85.10 | -- | 71.82 | -- | -- | -- |
| Altamira Therapeutics Ltd | 59.60k | -224.50k | 1.65m | 10.00 | 0.6445 | 0.1849 | -- | 27.74 | 0.6788 | 0.6788 | 0.0337 | 2.37 | 0.008 | -0.1997 | 3.36 | 5,960.18 | -2.99 | -66.27 | -5.77 | -113.27 | 150.61 | -- | -376.67 | -25,125.90 | 0.4268 | -- | 0.0634 | -- | -- | -- | 89.86 | -- | -- | -- |
| cbdMD Inc | 20.64m | -23.42m | 1.73m | 52.00 | -- | 0.5725 | -- | 0.084 | -18.95 | -18.95 | 7.85 | 0.8055 | 0.8817 | 2.01 | 20.35 | 396,856.90 | -82.98 | -38.59 | -112.36 | -41.50 | 63.43 | 63.80 | -94.12 | -87.98 | 0.5172 | -3.89 | 0.3128 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
| SOHM Inc | -100.00bn | -100.00bn | 1.82m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| InVitro International | 716.89k | 6.22k | 1.82m | 16.00 | 228.57 | 2.49 | -- | 2.54 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
| PainReform Ltd | 0.00 | -17.67m | 1.89m | 6.00 | -- | -- | -- | -- | -167.66 | -167.66 | 0.00 | -14.12 | 0.00 | -- | -- | 0.00 | -309.43 | -55.47 | -650.22 | -68.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -6.28 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.08m | 40.00 | -- | -- | -- | 0.7511 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to cbdMD Inc's reporting currency: US Dollar USD
3.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Connective Capital Management LLCas of 30 Sep 2024 | 89.22k | 2.37% |
| Two Sigma Securities LLCas of 30 Sep 2024 | 22.07k | 0.59% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 13.04k | 0.35% |
| Geode Capital Management LLCas of 30 Sep 2024 | 11.20k | 0.30% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 8.91k | 0.24% |
| UBS Securities LLCas of 30 Sep 2024 | 3.18k | 0.08% |
| Tower Research Capital LLCas of 30 Sep 2024 | 531.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2024 | 223.00 | 0.01% |
| Harbour Investments, Inc.as of 30 Sep 2024 | 159.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2024 | 68.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
